Structural assessment and biological evaluation of two N3S bombesin derivatives

Journal of Medicinal Chemistry

Volumn 52, Issue 14, 2009, Pages 4234-4246

  Gourni, Eleni ^a   Bouziotis, Penelope ^a   Benaki, Dimitra ^a   Loudos, George ^b   Xanthopoulos, Stavros ^a   Paravatou Petsotas, Maria ^a   Mavri Vavagianni, Maria ^c   Pelecanou, Maria ^a   Archimandritis, Spyros C ^a   Varvarigou, Alexandra D ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b UNIVERSITY OF WEST ATTICA   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BOMBESIN 1.1 RE 185; BOMBESIN 1.1 RE 187; BOMBESIN 1.1 TC 99M; BOMBESIN 1.1P RE 185; BOMBESIN 1.1P RE 187; BOMBESIN 1.1P TC 99M; BOMBESIN DERIVATIVE; DRUG METABOLITE; GASTRIN RELEASING PEPTIDE RECEPTOR; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING COMPETITION; CANCER MODEL; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DEGRADATION; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; DRUG UPTAKE; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN CELL; INTERNALIZATION; ISOTOPE LABELING; KIDNEY HOMOGENATE; LIVER HOMOGENATE; MALE; MOLECULAR STABILITY; MOUSE; NONHUMAN; PROSTATE CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOACTIVITY; RECEPTOR AFFINITY; SCID MOUSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOLID PHASE SYNTHESIS; STRUCTURE ACTIVITY RELATION; TIME; TISSUE DISTRIBUTION;

ANIMALS; BINDING, COMPETITIVE; BOMBESIN; CELL LINE, TUMOR; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; OLIGOPEPTIDES; ORGANOTECHNETIUM COMPOUNDS; PROTEIN STABILITY; PROTEIN TRANSPORT; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STAINING AND LABELING; TISSUE DISTRIBUTION;

EID: 67650726009     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm900360d     Document Type: Article

References (85)

1. Reubi, C. R. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr. Rev. 2003, 24 (4), 389-427.
2. Glunde, K.; Pathak, A. P.; Bhujwalla, Z. M. Molecular-functional imaging of cancer: to image and imagine. Trends Mol. Med. 2007, 13 (7), 287-303.
3. Kiaris, H.; Schally, A. V.; Sun, B.; Armatis, P.; Groot, K. Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin releasing peptide. Oncogene 1999, 18, 7168-7173.
4. Moody, T. W.; Desmond, N. C.; Cutitta, F.; Quattrocchi, K.; Minna, J. D. High affinity receptors for bombesin GRP-like peptides for human small cell lung carcinoma. Life Sci. 1985, 37, 105-113.
5. Chatzistamou, I.; Schally, A. V.; Sun, B.; Armatis, P.; Szepeshazi, K. Inhibition of growth of OV-1063 human epithelial ovarian cancers and c-jun and c-fos oncogene expression by bombesin antagonists. Br. J. Cancer 2000, 83, 906-913.
6. Charitopoulos, K. N.; Lazaris, A. C.; Aroni, K.; Kavantzas, N.; Nikolakopoulou, E.; Davaris, P. Immunodetection of gastrin-releasing peptide in malignant melanoma cells. Melanoma Res. 2000, 10, 345-400.
7. Rider, N. M.; Guha, S.; Hines, O. J.; Reber, H. A.; Rozengurt, E. G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation. J. Cell. Physiol. 2001, 186, 53-64.
8. Sun, B.; Schally, A. V.; Halmos, G. The presence of receptors for bombesin/Grp and mRNA for three receptor subtypes in human ovarian epithelial cancers. Regul. Pept. 2000, 90, 77-84.
9. Pansky, A.; de Weert, A.; Fasler, E.; Boulay, J. L.; Shulz, M.; Ketterer, S.; Selck, C.; Berlinger, C.; Von Schrenck, T.; Hildebrand P. Gastrin releasing peptide-preferring bombesin receptors mediate growth of human renal cell carcinoma. J. Am. Soc. Nephrol. 2000, 11, 1409-1418.
10. Markwalder, R.; Reubi, J. C. Gastrin releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer Res. 1999, 59, 1152-1159.
11. Halmos, G.; Wittliff, J. L.; Schally, A. V. Characterization of bombesin/gastrin-releasing receptors in human breast cancer and their relationship to steroid receptor expression. Cancer Res. 1995, 55, 280-287.
12. Zhang, H.; Chen, J.; Waldherr, C.; Hinni, K.; Waser, B.; Reubi, J. C.; Maecke H. R. Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors. Cancer Res. 2004, 64, 6707-6715.
13. Lin, K. S.; Luu, A.; Baidoo, K. E.; Hashemzadeh-Gargari, H., Chen, M. K.; Brenneman, K.; Pili, R.; Pomper, M.; Carducci M. A.; Wagner H. N., Jr. A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation. Bioconjugate Chem. 2005, 16, 43-50.
14. 99mTc: a preclinical study. J. Med. Chem. 2005, 48, 100-110.
15. Abd-Elgaliel, W. R.; Gallazzi, F.; Garrison, J. C.; Rold, T. L.; Sieckman, G. L.; Figueroa, S. D.; Hoffman, T. J.; Lever, S. Z. Design, synthesis and biological evaluation of an antagonist-bombesin analogue as targeting vector. Bioconjugate Chem. 2008, 19, 2040-2048.
16. Anastasi, A.; Erspamer, V.; Bucci, M. Isolation and structure of bombesin and alytesin, two analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia 1971, 27, 166-167.
17. McDonald, T. J.; Jornvall, H.; Nilsson, G. Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem. Biophys. Res. Commun. 1979, 90, 227-233.
18. Sunday, M. E.; Kaplan, L. M.; Motoyama, E.; Chin, W. W.; Spindel, E. R. Gastrin releasing peptide (mammalian bombesin) gene expression in health and disease. Lab. Invest. 1988, 59, 5-24.
19. Wada, E.; Way, J.; Shapira, H.; Kusano, K.; Lebacq-Verheyden, A. M.; Coy, D.; Jensen, R.; Battey, J. F. cDNA cloning, characterization and brain region-specific expression of a neuromedin-B preferring bombesin receptor. Neuron 1991, 6, 421-430.
20. Van De Wiele, C.; Dumont, F.; Van Belle, S.; Slegers, G.; Peers, S. H.; Derricks, R. A. Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumor imaging? Nucl. Med. Com. 2001, 22, 5-15.
21. Kroog, G. S.; Jian, X.; Chen, L.; Northup, J. K.; Battey, J. F. Phosphorylation uncouples the gastrin-releasing-peptide receptor from G(q). J. Biol. Chem. 1999, 274, 36700-36707.
22. Spindel, E. R.; Giladi, E.; Brehm, P.; Goodman, R. H.; Segerson, T. P. Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/gastrin-releasing peptide receptor. Mol. Endocrinol. 1990, 4, 1956-1963.
23. Fathi, Z.; Corjay, M. H.; Shapira, H.; Wada, E.; Benya, R.; Jensen, R.; Viallet, J.; Sausville, E. A.; Battey, J. F. BRS-3: novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. J. Biol. Chem. 1993, 268, 5979-5984.
24. Smith, C. J.; Volkert, W. A.; Hoffman, T. J. Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update. Nucl. Med. Biol. 2003, 30, 861-868.
25. 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells. J. Nucl. Med. 2003, 44, 823-831.
26. 111In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy. J. Nucl. Med. 2002, 43, 1650-1656.
27. 3]bombesin in human prostate adenocarcinoma xenografts. J. Nucl. Med. 2004, 45, 1390-1397.
28. 68Ga-labeled DOTA-derivatised peptide ligands. Eur. J. Nucl. Med. 2004, 31, 1097-1104.
29. 2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells. Nucl. Med. Biol. 2003, 30, 101-109.
30. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. J. Nucl. Med., 2006, 47, 492-501.
31. 99mTc-Labeled small peptides as diagnostic radiopharmaceuticals. Chem. Rev. 1999, 99, 2235-2268.
32. 99mTc-RP527, a gastrin-releasing peptide(GRP) agonist for the visualization of GRP receptor-expressing malignancies. J. Nucl. Med. 2001, 42, 1722-1727.
33. Varvarigou, A.; Bouziotis, P.; Zikos, C.; Scopinaro, F.; De Vincentis, G. Gastrin-releasing peptide (GRP) analogues for cancer imaging. Cancer Biother. Radiopharm. 2004, 19, 219-229.
34. 99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumor imaging. Eur. J. Nucl. Med. 2003, 30, 247-258.
35. 99mTc-labeling and in vivo studies of a bombesin analogue with novel watersoluble dithiadiphosphine- based bifunctional chelating agent. Bioconjugate Chem. 1999, 10, 254-260.
36. 99mTc-labeled bombesinlike peptides for early cancer detection. Anticancer Res. 2006, 26, 435-438.
37. 99mTc-labeled bombesinlike peptide. Cancer Biother. Radiopharm. 2002, 17, 317-326.
38. Okarvi, S. M.; Jammaz, I. Synthesis, radiolabeling, and biological characteristics of a bombesin peptide analog as a tumor imaging agent. Anticancer Res. 2003, 23, 2745-2750.
39. 2: An in vivo/in vitro structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties. Bioconjugate Chem. 2003, 14, 93-102.
40. 2 (X = seylserylserine, glycylglycylglycine, glycylserylglycine, or beta alanine). Synth. React. Inorg. Met.-Org., Nano-Met. Chem. 2006, 36, 481-491.
41. 99mTc(I)-labeled bombesin analogue for imaging gastrin releasing peptide receptor-positive tumors. Nucl. Med. Biol. 2002, 29, 553-560.
42. 3 bombesin analogues. Nucl. Med. Biol. 2007, 34, 17-28.
43. 1. Cancer Res. 2003, 15, 4082-4088.
44. + moiety. Nucl. Med. Biol. 2006, 33, 625-634.
45. Maina, T.; Nock, B.; Mather, S. Targeting prostate cancer with radiolabelled bombesins. Cancer Imaging 2006, 6, 153-157.
46. Seo, Y.; Kurhanewicz, J.; Franc, B. L.; Hawkins, R. A.; Hasegawa, B. H. Improved prostate cancer imaging with SPECT/CT and MRI/MRSI. IEEE Trans. Nucl. Sci. 2005, 52 (5), 1316-1320.
47. Swanson, M. G.; Vigneron, D. B.; Tran, T. K.; Kurhanewicz, J. Magnetic resonance imaging and spectroscopic imaging of prostate cancer. Cancer Invest. 2001, 19, 510-523.
48. Jadvar, H.; Pinski, J. K.; Conti, P. S. FDG PET in suspected recurrent and metastatic prostate cancer. Oncol. Rep. 2003, 10, 1485-1488.
49. 18F]fluorodeoxyglucose-positron emission tomography. J. Urol. 2003, 169, 1337-1340.
50. Hara, T.; Kosaka, N.; Kishi, H. Development of (18)F-fluoroethyl-choline for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging. J. Nucl. Med. 2002, 43, 187-199.
51. Jankowsky, R.; Kirsch, S.; Reich, T.; Spies, H.; Johannsen, B. Solution structure of rhenium(V) oxo peptide complexes of glycylglycylcysteine and cysteinylglycine as studied by capillary electrophoresis and X-ray absorption spectroscopy. J. Inorg. Biochem. 1998, 70, 99-106.
52. Gourni, E.; Bouziotis, P.; Zikos, C.; Loudos, G.; Xanthopoulos, S.; Fani, M.; Archimandritis, S. C.; Varvarigou, A. D. Comparative in vivo evaluation of two novel Tc-99m labeled bombesin derivatives. Nucl. Instrum. Methods A 2006, 569, 518-521.
53. Deutsch, E.; Libson, K.; Vanderheyden, J.-L.; Ketring, A. R.; Maxon, H. R. The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine. Nucl. Med. Biol. 1986, 13, 465-477.
54. Wuthrich, K. NMR of Proteins and Nucleic Acids; Wiley-Interscience Publication: New York, 1986; pp 130-161.
55. Lever, S. Z.; Baidoo, K. E.; Mahmood, A. Structure proof of syn/ anti isomerism in N-alkylated diaminedithiol (DADT) complexes of technetium. Inorg. Chim. Acta 1990, 176, 183-184.
56. Francesconi, L. C.; Graczyk, G.; Wehrli, S.; Shaikh, S. N.; McClinton, D.; Liu, S.; Zubieta, J.; Kung, H. F. Synthesis and characterization of neutral MVO (M = technetium, rhenium) amine-thiol complexes containing a pendant phenylpiperidine group. Inorg. Chem. 1993, 32, 3114-3124.
57. Pelecanou, M.; Chryssou, K., Stassinopoulou, C. I. Trends in NMR chemical shifts and ligand mobility of TcO(V) and ReO(V) complexes with aminothiols. J. Inorg. Biochem. 2000, 79, 347-351.
58. 99mTc labeling of highly potent small peptides. Bioconjugate Chem. 1997, 8, 621-636.
59. 99mTc: a reflection on technetium core structures and a strategy for new chelate design. Nucl. Med. Biol. 2005, 32, 1-20.
60. Lister-James, J.; Knight, L. C.; Mauer, A. H.; Bush, L. R.; Mayer, B. R.; Dean, R. T. Thrombus imaging with a technetium-99m-labeled, activated platelet receptor-binding peptide. J. Nucl. Med. 1996, 37, 775-781.
61. Pearson, D. A.; Lister-James, J.; McBride, W. J.; Wilson, D. M.; Martel, L. J.; Civitello, E. R.; Taylor, J. E.; Moyer, B. R.; Dean, R. T. Somatostatin receptor-binding peptides labeled with technetium-99m: chemistry and initial biological studies. J. Med. Chem. 1996, 39, 1361-1371.
62. 99mTc. Q. J. Nucl. Med. 1996, 40, 221-233.
63. Jankowsky, R.; Kirsch, S.; Reich, T.; Spies, H.; Johannsen, B. Solution structures of rhenium(V) oxo peptide complexes of glycylglycylcysteine and cysteinylglycine as studied by capillary electrophoresis and X-ray absorption spectroscopy. J. Inorg. Biochem. 1998, 70, 99-106.
64. 2N′S peptidic chelator: evidence of interconversion between the syn and anti conformations. Inorg. Chem. 1997, 36, 5799-5808.
65. Takayama, T.; Suzuki, K.; Sekine, T.; Kudo, H. Syntheses and structures of technetium(V) and rhenium(V) oxo complexes of peptide having KYC-sequence. Radiochim. Acta 2000, 88, 247-251.
66. Wong, E.; Bennett, S.; Lawrence, B.; Fauconnier, T. Lu, L. F. L.; Bell, R. A.; Thornback, J. R.; Eshima, D. Tuftsin receptor-binding peptide labeled with technetium: chemistry and preliminary in vitro receptor-binding study. Inorg. Chem. 2001, 40, 5695-5700.
67. 99Tc chelate-bombesin derived peptide conjugate. Inorg. Chim. Acta 2001, 325, 155-163.
68. 99mTc peptide targeted radiopharmaceuticals. Inorg. Chem. 2007, 46, 7326-7340.
69. 99TcO] apcitide: a technetium labeled peptide. Inorg. Chem. 2004, 43, 2867-2875.
70. 99mTc]technetium depreotide: a somatostatin receptor binding tumor imaging. J. Med. Chem. 2007, 50, 4295-4303.
71. 1H-NMR techniques. Eur. J. Biochem. 1987, 168,193-199.
72. Cavatorta, P.; Spisni, A.; Szabo, A. G.; Farruggia, G.; Franzoni, L.; Masotti, L. Conformation of bombesin in buffer and in the presence of lysolecithin micelles: NMR, CD, and fluorescence studies. Biopolymers 1989, 28, 441-463.
73. 2 GRP receptor-targeted radiotherapy and chemotherapy in PC-3 human prostate tumor cell xenografted SCID mice. Cancer Biother. Radiopharm. 2006, 21, 155-166.
74. 99mTc-labeled neuropeptides using stabilised peptide analogues. Cancer Biother. Radiopharm. 2004, 19, 181-188.
75. Preston, E.; Miller, G. V.; Primrose, J. N. Bombesin-like peptides and cancer. Crit. Rev. Oncol. Hematol. 1996, 23, 225-238.
76. Faintuch, B. L.; Teorodo, R.; Duatti, A.; Muramoto, E.; Faintuch, S.; Smith C. J. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies. Nucl. Med. Biol. 2008, 35, 401-411.
77. Smith, C. J.; Volkert, W. A.; Hoffman, T. J. Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes. Nucl. Med. Biol. 2005, 32, 733-740.
78. 125I-[Tyr4]bombesin by tumor cells. Prostate 1994, 25, 29-38.
79. Moran, T. H.; Moody, T. W.; Hostetler, A. M.; Robinson, P. H.; Goldrich, M.; McHugh, P. R. Distribution of bombesin binding sites in the rat gastrointestinal tract. Peptides 1988, 9, 643-649.
80. Cescato, R.; Maina, T.; Nock, B.; Nikolopoulou, A.; Charalabidis, D.; Piccand, V.; Reudi, J. C. Bombesin receptor antagonists may be preferable to agonists for tumor imaging. J. Nucl. Med. 2008, 49, 318-326.
81. 2 with favorable properties for SPECT imaging of colon cancer. Bioconjugate Chem. 2008, 19, 1170-1178.
82. 3-DTMA bombesin conjugates having high affinity for the GRP receptor. Nucl. Med. Biol. 2008, 35, 263-272.
83. Maina, T.; Nock, B. A.; Zhang, H.; Nikolopoulou, A.; Waser, B.; Reudi, J. C. Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs. J. Nucl. Med. 2005, 46, 823-830.
84. Noll, B.; Kniess, M.; Friebe, M.; Spies, H.; Johannsen, B. Rhenium (V) gluconate, a suitable precursor for the preparation of rhenium (V) complexes. Isot. Environ. Health Stud. 1996, 32, 21-29.
85. Loudos, G.; Majewski, S.; Wojcik, R.; Weisenberger, A.; Sakellios, N.; Nikita, K.; Uzunoglu, N.; Bouziotis, P.; Xanthopoulos, S.; Varvarigou, A. Performance evaluation of a dedicated camera suitable for dynamic radiopharmaceuticals evaluation in small animals. IEEE Trans. Nucl. Soc. 2007, 54-59.